Use of Capecitabine as First-Line Therapy in Patients with Metastatic Breast Cancer Relapsing After High-Dose Chemotherapy and Autologous Stem Cell Support

Metastatic Breast ◽

High Dose Chemotherapy ◽

High Dose ◽

First Line ◽

Stem Cell Support ◽

First Line Therapy ◽

Line Therapy ◽

Use of Capecitabine as First-Line Therapy in Patients with Metastatic Breast Cancer Relapsing After High- Dose Chemotherapy and Autologous Stem Cell Support

Clinical Oncology ◽

10.1053/clon.2001.9307 ◽

2001 ◽

Vol 13 (6) ◽

pp. 434-437

Author(s):

A. Bashey ◽

S. Sundaram ◽

S. Corringham ◽

V. Jones ◽

D. Lancaster ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast ◽

High Dose Chemotherapy ◽

High Dose ◽

First Line ◽

Stem Cell Support ◽

First Line Therapy ◽

Line Therapy ◽

HER2 overexpression as a prognostic factor in metastatic breast cancer patients treated with high-dose chemotherapy and autologous stem cell support

10.1038/sj.bmt.1704619 ◽

2004 ◽

Vol 34 (5) ◽

pp. 413-417 ◽

Cited By ~ 7

Author(s):

V Guarneri ◽

C Bengala ◽

C Orlandini ◽

A Gennari ◽

S Donati ◽

...

Keyword(s):

Breast Cancer ◽

Stem Cell ◽

Metastatic Breast ◽

High Dose Chemotherapy ◽

High Dose ◽

Her2 Overexpression ◽

Breast Cancer Patients ◽

Stem Cell Support ◽

Single-Agent Paclitaxel in Patients With Metastatic Breast Cancer Receiving High-Dose Chemotherapy With Peripheral Blood Stem Cell Support

American Journal of Clinical Oncology ◽

10.1097/00000421-199904000-00011 ◽

1999 ◽

Vol 22 (2) ◽

pp. 162-167

Author(s):

L. S. Schwartzberg ◽

C. H. Weaver ◽

R. Birch ◽

R. Giudice ◽

E. Sobong ◽

...

Keyword(s):

Breast Cancer ◽

Stem Cell ◽

Peripheral Blood Stem Cell ◽

Single Agent ◽

Metastatic Breast ◽

High Dose Chemotherapy ◽

High Dose ◽

Stem Cell Support ◽

A phase II study of two cycles of high-dose chemotherapy with autologous stem cell support in patients with metastatic breast cancer who meet eligibility criteria for a single cycle

10.1038/sj.bmt.1702172 ◽

2000 ◽

Vol 25 (5) ◽

pp. 519-524 ◽

Cited By ~ 6

Author(s):

A Bashey ◽

S Corringham ◽

J Garrett ◽

TA Lane ◽

EA Gilpin ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii Study ◽

Metastatic Breast ◽

High Dose Chemotherapy ◽

High Dose ◽

Single Cycle ◽

Eligibility Criteria ◽

Stem Cell Support ◽

Expression of C-erbB-2/HER-2 in patients with metastatic breast cancer undergoing high-dose chemotherapy and autologous blood stem cell support

10.1038/sj.bmt.1701907 ◽

1999 ◽

Vol 24 (4) ◽

pp. 377-384 ◽

Cited By ~ 19

Author(s):

M Bewick ◽

T Chadderton ◽

M Conlon ◽

R Lafrenie ◽

D Morris ◽

...

Keyword(s):

Breast Cancer ◽

Stem Cell ◽

Autologous Blood ◽

Metastatic Breast ◽

High Dose Chemotherapy ◽

High Dose ◽

Stem Cell Support ◽

Her 2 ◽

PET-FDG Imaging in Metastatic Breast Cancer Treated with High Dose Chemotherapy and Stem Cell Support.

10.21236/ada319987 ◽

1996 ◽

Author(s):

Abass Alavi

Keyword(s):

Breast Cancer ◽

Stem Cell ◽

Metastatic Breast ◽

High Dose Chemotherapy ◽

High Dose ◽

Stem Cell Support ◽

Stem Cell Dose and Tumorbiologic Parameters as Prognostic Markers for Patients with Metastatic Breast Cancer Undergoing High-Dose Chemotherapy with Autologous Blood Stem Cell Support

Stem Cells ◽

10.1634/stemcells.20-1-32 ◽

2002 ◽

Vol 20 (1) ◽

pp. 32-40 ◽

Cited By ~ 7

Author(s):

Manfred Hensel ◽

Andreas Schneeweiss ◽

Hans-Peter Sinn ◽

Gerlinde Egerer ◽

Martin Kornacker ◽

...

Keyword(s):

Breast Cancer ◽

Stem Cell ◽

Prognostic Markers ◽

Autologous Blood ◽

Metastatic Breast ◽

High Dose Chemotherapy ◽

High Dose ◽

Stem Cell Support ◽

A randomized trial of high-dose chemotherapy (HDCT) with autologous peripheral blood stem cell support (asct) compared to standard chemo therapy (ct) in women with metastatic breast cancer: a National Cancer Institute of Canada (NCIC) clinical trials group study

European Journal of Cancer ◽

10.1016/s0959-8049(01)81543-4 ◽

2001 ◽

Vol 37 ◽

pp. S285 ◽

Cited By ~ 14

Author(s):

S. Gluck ◽

M. Crump ◽

D. Stewart ◽

M. Levine ◽

K. Pritchard ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trials ◽

Stem Cell ◽

Peripheral Blood Stem Cell ◽

Metastatic Breast ◽

High Dose Chemotherapy ◽

High Dose ◽

Stem Cell Support ◽

High-dose chemotherapy and autologous stem cell support followed by post-transplant doxorubicin and taxol as initial therapy for metastatic breast cancer: hematopoietic tolerance and efficacy

10.1038/sj.bmt.1701263 ◽

1998 ◽

Vol 21 (12) ◽

pp. 1207-1211 ◽

Cited By ~ 10

Author(s):

M deMagalhaes-Silverman ◽

L Hammert ◽

B Lembersky ◽

J Lister ◽

W Rybka ◽

...

Keyword(s):

Breast Cancer ◽

Stem Cell ◽

Metastatic Breast ◽

High Dose Chemotherapy ◽

Initial Therapy ◽

High Dose ◽

Stem Cell Support ◽

Post Transplant ◽

High-dose chemotherapy with autologous stem-cell support versus standard-dose chemotherapy: meta-analysis of individual patient data from 6 randomized metastatic breast cancer trials.

10.1158/0008-5472.sabcs-6113 ◽

2009 ◽

Cited By ~ 1

Author(s):

DA Berry ◽

NT Ueno ◽

MM Johnson ◽

X Lei ◽

DA Smith ◽

...

Keyword(s):

Breast Cancer ◽

Individual Patient Data ◽

Standard Dose ◽

Meta Analysis ◽

Metastatic Breast ◽

High Dose Chemotherapy ◽

High Dose ◽

Stem Cell Support ◽